BioSpace News Archive

DNA mismatch repair deficiency (MMRd) is a genetic condition often associated with colon cancer.

Kewaunee Scientific Corporation announces the Company’s new LOOKBOOK, which will be rolled out globally during the 2023 Arablab Live tradeshow and conference being held in Dubai during September 19-21.

MAPS Public Benefit Corporation (“MAPS PBC”) announced that data from the company’s MAPP2 clinical trial, a multi-site Phase 3 study of MDMA-assisted therapy for post–traumatic stress disorder (“PTSD”), was published in the September issue of Nature Medicine.

Curasight A/S (“Curasight” or the “Company” - TICKER: CURAS) announces today that the previously announced results from the investigator-initiated phase II study using uPAR-PET (uTRACE®) in primary brain cancer have been presented in an oral presentation at the World Molecular Imaging Congress (WMIC) 2023 in Prague.

Automated Control Concepts, a leading innovator in biotechnology solutions, announced the next release of its cutting-edge bioreactor control and data platform, Lab Owl, with new advancements that promise to redefine the landscape of bioprocessing.

In one of the first studies of healthcare resource utilization and costs for patients with rare disease, the EveryLife Foundation for Rare Diseases reveals that timely diagnosis and screening can shorten and possibly eliminate the diagnostic odyssey while significantly reducing the cost impact of rare disease for individuals, families, and the healthcare system.

Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEVÔ)

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone, today announced the appointments of Daphne Karydas and Glenn Sblendorio to its Board of Directors (the Board).

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) today announced that members of its senior management will participate in a fireside chat at the upcoming 2023 Cantor Global Healthcare Conference in New York, NY on Thursday, September 28, 2023 at 3:00pm Eastern Time.

Heart Test Laboratories, Inc.d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) today provided a business update and reported financial results for the first quarter fiscal 2024 ended July 31, 2023.